HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3)
Submitted: June 24, 2013
Accepted: June 24, 2013
Published: June 24, 2013
Accepted: June 24, 2013
Abstract Views: 1747
PDF: 1651
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.